Inflammatory Cytokine Patterns Associated with Neurological Diseases in Coronavirus Disease 2019
Patients with coronavirus disease 2019 (COVID‐19) can present with distinct neurological manifestations. This study shows that inflammatory neurological diseases were associated with increased levels of interleukin (IL)‐2, IL‐4, IL‐6, IL‐10, IL‐12, chemokine (C‐X‐C motif) ligand 8 (CXCL8), and CXCL10 in the cerebrospinal fluid. Conversely, encephalopathy was associated with high serum levels of IL‐6, CXCL8, and active tumor growth factor β1. Inflammatory syndromes of the central nervous system in COVID‐19 can appear early, as a parainfectious process without significant systemic involvement, or without direct evidence of severe acute respiratory syndrome coronavirus 2 neuroinvasion. At the same time, encephalopathy is mainly influenced by peripheral events, including inflammatory cytokines. ANN NEUROL 2021;89:1041–1045.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:89 |
|---|---|
| Enthalten in: |
Annals of Neurology - 89(2021), 5, Seite 1041-1045 |
| Beteiligte Personen: |
Espíndola, Otávio M. [VerfasserIn] |
|---|
| BKL: |
|---|
| Anmerkungen: |
© 2021 American Neurological Association |
|---|
| Umfang: |
5 |
|---|
| doi: |
10.1002/ana.26041 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY001701738 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY001701738 | ||
| 003 | DE-627 | ||
| 005 | 20230307110007.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230210s2021 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1002/ana.26041 |2 doi | |
| 028 | 5 | 2 | |a ANA_ANA26041.xml |
| 035 | |a (DE-627)WLY001701738 | ||
| 035 | |a (WILEY)ANA26041 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 084 | |a 44.90 |2 bkl | ||
| 084 | |a 44.67 |2 bkl | ||
| 100 | 1 | |a Espíndola, Otávio M. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Inflammatory Cytokine Patterns Associated with Neurological Diseases in Coronavirus Disease 2019 |
| 264 | 1 | |c 2021 | |
| 300 | |a 5 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2021 American Neurological Association | ||
| 520 | |a Patients with coronavirus disease 2019 (COVID‐19) can present with distinct neurological manifestations. This study shows that inflammatory neurological diseases were associated with increased levels of interleukin (IL)‐2, IL‐4, IL‐6, IL‐10, IL‐12, chemokine (C‐X‐C motif) ligand 8 (CXCL8), and CXCL10 in the cerebrospinal fluid. Conversely, encephalopathy was associated with high serum levels of IL‐6, CXCL8, and active tumor growth factor β1. Inflammatory syndromes of the central nervous system in COVID‐19 can appear early, as a parainfectious process without significant systemic involvement, or without direct evidence of severe acute respiratory syndrome coronavirus 2 neuroinvasion. At the same time, encephalopathy is mainly influenced by peripheral events, including inflammatory cytokines. ANN NEUROL 2021;89:1041–1045 | ||
| 700 | 1 | |a Gomes, Yago C. P. |4 aut | |
| 700 | 1 | |a Brandão, Carlos Otávio |4 aut | |
| 700 | 1 | |a Torres, Rafael C. |4 aut | |
| 700 | 1 | |a Siqueira, Marilda |4 aut | |
| 700 | 1 | |a Soares, Cristiane N. |4 aut | |
| 700 | 1 | |a Lima, Marco Antonio S. D. |4 aut | |
| 700 | 1 | |a Leite, Ana Claudia C. B. |4 aut | |
| 700 | 1 | |a Venturotti, Carolina O. |4 aut | |
| 700 | 1 | |a Carvalho, Ana Julia C. |4 aut | |
| 700 | 1 | |a Torezani, Guilherme |4 aut | |
| 700 | 1 | |a Araujo, Abelardo Q. C. |4 aut | |
| 700 | 1 | |a Silva, Marcus Tulius T. |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of Neurology |g 89(2021), 5, Seite 1041-1045 |w (DE-627)WLY001695479 |x 15318249 |7 nnns |
| 773 | 1 | 8 | |g volume:89 |g year:2021 |g number:5 |g pages:1041-1045 |g extent:5 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 936 | b | k | |a 44.90 |q ASE |
| 936 | b | k | |a 44.67 |q ASE |
| 951 | |a AR | ||
| 952 | |d 89 |j 2021 |e 5 |h 1041-1045 |g 5 | ||